Argenx SE (ARGX) a favorite Biotech setting up after slipping below 1-year VPOC on Monday it rallied to close above and provides a solid reward/risk entry. ARGX needs to clear $378 and then the 21-MA which would leave room to $400 and likely new highs while the rising 200-MA near $355 likely supportive followed by $340 as VWAP from the 2022 low.